NCT03939884View on ClinicalTrials.gov

MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain.

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

February 25, 2018

Study Completion Date

February 25, 2018

Conditions

Pain

Interventions

DRUG

MuscleCare Topical Product

Application of the product will be applied with six circular applications over the trigger point and left to rest for 7 minutes.

DRUG

Voltaren Topical

Application of the product will be applied with six circular applications over the trigger point and left to rest for 7 minutes.

DRUG

Nivea, Topical Cream

Application of the product will be applied with six circular applications over the trigger point and left to rest for 7 minutes.

Trial Locations (1)

Unknown

University of Toronto, Toronto

All Listed Sponsors

collaborator

Active and Innovative Inc.

OTHER

lead

University of Toronto

OTHER

NCT03939884 - MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain. | Biotech Hunter | Biotech Hunter